FDA Approval: On-X Aortic Valves With Less Warfarin
Thousands of Americans with On-X Aortic Heart Valves may be able to reduce their regular blood-thinning medication regimen, thanks to an expanded labeling claim just granted by the U.S. Food and Drug Administration (FDA) to On-X Life Technologies Inc. (ON-X LTI), the company announced recently.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news
More News: Cardiology | Coumadin | Food and Drug Administration (FDA) | Heart | Heart Valve Disease | Heart Valves | Medical Devices | Warfarin